Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

This study has been completed.
VA Office of Research and Development
Information provided by (Responsible Party):
Centers for Disease Control and Prevention Identifier:
First received: September 6, 2001
Last updated: June 4, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Primary Completion Date: February 2004 (Final data collection date for primary outcome measure)